@article{1a2a4076a3f84f9c8803746399536d31,
title = "Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease",
abstract = "Background: Plasma proteins are critical mediators of cardiovascular processes and are the targets of many drugs. Previous efforts to characterize the genetic architecture of the plasma proteome have been limited by a focus on individuals of European descent and leveraged genotyping arrays and imputation. Here we describe whole genome sequence analysis of the plasma proteome in individuals with greater African ancestry, increasing our power to identify novel genetic determinants. Methods: Proteomic profiling of 1301 proteins was performed in 1852 Black adults from the Jackson Heart Study using aptamer-based proteomics (SomaScan). Whole genome sequencing association analysis was ascertained for all variants with minor allele count ≥5. Results were validated using an alternative, antibody-based, proteomic platform (Olink) as well as replicated in the Multi-Ethnic Study of Atherosclerosis and the HERITAGE Family Study (Health, Risk Factors, Exercise Training and Genetics). Results: We identify 569 genetic associations between 479 proteins and 438 unique genetic regions at a Bonferroni-adjusted significance level of 3.8×10-11. These associations include 114 novel locus-protein relationships and an additional 217 novel sentinel variant-protein relationships. Novel cardiovascular findings include new protein associations at the APOE gene locus including ZAP70 (sentinel single nucleotide polymorphism [SNP] rs7412-T, β=0.61±0.05, P=3.27×10-30) and MMP-3 (β=-0.60±0.05, P=1.67×10-32), as well as a completely novel pleiotropic locus at the HPX gene, associated with 9 proteins. Further, the associations suggest new mechanisms of genetically mediated cardiovascular disease linked to African ancestry; we identify a novel association between variants linked to APOL1-associated chronic kidney and heart disease and the protein CKAP2 (rs73885319-G, β=0.34±0.04, P=1.34×10-17) as well as an association between ATTR amyloidosis and RBP4 levels in community-dwelling individuals without heart failure. Conclusions: Taken together, these results provide evidence for the functional importance of variants in non-European populations, and suggest new biological mechanisms for ancestry-specific determinants of lipids, coagulation, and myocardial function.",
keywords = "Cardiovascular disease, genetics, proteomics, race and ethnicity",
author = "Katz, {Daniel H.} and Tahir, {Usman A.} and Bick, {Alexander G.} and Akhil Pampana and Debby Ngo and Benson, {Mark D.} and Zhi Yu and Robbins, {Jeremy M.} and Chen, {Zsu Zsu} and Cruz, {Daniel E.} and Shuliang Deng and Laurie Farrell and Sumita Sinha and Schmaier, {Alec A.} and Dongxiao Shen and Yan Gao and Hall, {Michael E.} and Adolfo Correa and Tracy, {Russell P.} and Peter Durda and Taylor, {Kent D.} and Yongmei Liu and Johnson, {W. Craig} and Xiuqing Guo and Jie Yao and Chen, {Yii Der Ida} and Manichaikul, {Ani W.} and Deepti Jain and Claude Bouchard and Sarzynski, {Mark A.} and Rich, {Stephen S.} and Rotter, {Jerome I.} and Wang, {Thomas J.} and Wilson, {James G.} and Pradeep Natarajan and Gerszten, {Robert E.}",
note = "Funding Information: Dr Katz is supported by a NHLBI T32 postdoctoral training grant (T32HL007374-40). Dr Tahir is supported by the Ruth L. Kirchstein postdoctoral individual National Research Award (F32HL150992). Dr Bick is supported by National Institutes of Health (NIH) DP5-OD029586-01 and is a recipient of a Career Award for Medical Scientists from the Burroughs Wellcome Foundation. Dr Cruz is supported by the KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst (NIH/National Center for Advancing Translational Sciences Award TR002542). Dr Robbins is supported by the John S. LaDue Memorial Fellowship in Cardiology at Harvard Medical School. Dr Benson is supported by a NHLBI K08HL145095 award. Dr Natarajan is supported by NIH R01HL142711. Drs Gerszten, Wang, and Wilson are supported by NIH R01 DK081572. Drs Gerszten, Wang, and Vasan are supported by NIH R01 HL132320. Drs Gerszten and Vasan are supported by National Institute on Aging grant RF1AG063507. Funding Information: The MESA projects are conducted and supported by the NHLBI in collaboration with MESA investigators. Support for MESA is provided by contracts 75N92020D00001, HHSN268201500003I, N01-HC-95159, 75N92020D00005, N01-HC-95160, 75N92020D00002, N01-HC-95161, 75N92020D00003, N01-HC-95162, 75N92020D00006, N01-HC-95163, 75N92020D00004, N01-HC-95164, 75N92020D00007, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169, UL1-TR-000040, UL1-TR-001079, and UL1-TR-001420. It is also supported in part by the National Center for Advancing Translational Sciences, Clinical and Translational Science Institute (CTSI) grant UL1TR001881, and National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center grant DK063491 to the Southern California Diabetes Endocrinology Research Center. Funding Information: This research was partially funded by NHLBI grants HL-45670, HL-47317, HL-47321, HL-47323, and HL-47327, all in support of the HERITAGE Family Study. C.B. is partially funded by the John W. Barton Sr Chair in Genetics and Nutrition, and NIH Centers of Biomedical Research Excellence grant (NIH P30GM118430-01). Dr Sarzynski is supported by R01HL146462. Publisher Copyright: {\textcopyright} 2022 Lippincott Williams and Wilkins. All rights reserved.",
year = "2022",
month = feb,
day = "1",
doi = "10.1161/CIRCULATIONAHA.121.055117",
language = "English (US)",
volume = "145",
pages = "357--370",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "5",
}